Radiation Oncology Radiosensitization by 2-benzoyl-3-phenyl-6,7-dichloroquinoxaline 1,4-dioxide under Oxia and Hypoxia in Human Colon Cancer Cells
暂无分享,去创建一个
Hala Gali-Muhtasib | Fady Geara | H. Gali-Muhtasib | Wafic Itani | F. Geara | Joelle Haykal | M. Haddadin | Wafica Itani | Joelle Haykal | Makhluf Haddadin
[1] A. López de Cerain,et al. New quinoxalinecarbonitrile 1,4-di-N-oxide derivatives as hypoxic-cytotoxic agents. , 2000, European journal of medicinal chemistry.
[2] H. Gali-Muhtasib,et al. Quinoxaline 1,4-dioxides are novel angiogenesis inhibitors that potentiate antitumor effects of ionizing radiation. , 2004, International journal of oncology.
[3] H. Gali-Muhtasib,et al. Quinoxaline 1,4‐dioxides: Hypoxia‐selective therapeutic agents , 2002, Molecular carcinogenesis.
[4] W. El-Deiry. The role of p53 in chemosensitivity and radiosensitivity , 2003, Oncogene.
[5] Stephen N. Jones,et al. Regulation of p53 stability by Mdm2 , 1997, Nature.
[6] K. Yoneda,et al. Mn‐SOD antisense upregulates in vivo apoptosis of squamous cell carcinoma cells by anticancer drugs and γ‐rays regulating expression of the BCL‐2 family proteins, COX‐2 and p21 , 2001, International journal of cancer.
[7] Giuseppe Schettino,et al. New insights on cell death from radiation exposure. , 2005, The Lancet. Oncology.
[8] P. Vaupel,et al. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. , 2001, Journal of the National Cancer Institute.
[9] S. Welz,et al. Hypoxic radiosensitizers and hypoxic cytotoxins in radiation oncology. , 2003, Current medicinal chemistry. Anti-cancer agents.
[10] K. Fukuchi,et al. Phosphatidylinositol 3-kinase inhibitors, Wortmannin or LY294002, inhibited accumulation of p21 protein after gamma-irradiation by stabilization of the protein. , 2000, Biochimica et biophysica acta.
[11] J. Masferrer,et al. COX-2 Inhibitors as Radiosensitizing Agents for Cancer Therapy , 2003, American journal of clinical oncology.
[12] Johan Bussink,et al. Clinical studies of hypoxia modification in radiotherapy. , 2004, Seminars in radiation oncology.
[13] Y. Matsui,et al. Effects of p53 Mutations on Cellular Sensitivity to Ionizing Radiation , 2001, American journal of clinical oncology.
[14] James B. Mitchell,et al. Effects of hypoxia on radiation-responsive stress-activated protein kinase, p53, and caspase 3 signals in TK6 human lymphoblastoid cells. , 2005, Cancer research.
[15] A. Levine,et al. Cyclooxygenase-2 Suppresses Hypoxia-induced Apoptosis via a Combination of Direct and Indirect Inhibition of p53 Activity in a Human Prostate Cancer Cell Line* , 2005, Journal of Biological Chemistry.
[16] G. Chowdhury,et al. Redox-activated, hypoxia-selective DNA cleavage by quinoxaline 1,4-di-N-oxide. , 2001, Bioorganic & medicinal chemistry.
[17] J. Brown,et al. Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. , 2000, Molecular medicine today.
[18] I. Stratford,et al. Pharmacological and biological evaluation of a series of substituted 1,4-naphthoquinone bioreductive drugs. , 2004, Biochemical pharmacology.
[19] W. El-Deiry,et al. Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.
[20] Z. Szewczuk,et al. Direct solid-phase synthesis of quinoxaline-containing peptides , 2005 .
[21] M. V. Heiden,et al. Redox regulation of p53 during hypoxia , 2000, Oncogene.
[22] Y Taya,et al. Inhibition of cyclin-dependent kinase 2 by p21 is necessary for retinoblastoma protein-mediated G1 arrest after gamma-irradiation. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[23] Peter Vaupel,et al. Tumor microenvironmental physiology and its implications for radiation oncology. , 2004, Seminars in radiation oncology.
[24] H. Choy,et al. Enhancing radiotherapy with cyclooxygenase-2 enzyme inhibitors: a rational advance? , 2003, Journal of the National Cancer Institute.
[25] E. Reyt,et al. Chronic hypoxia protects against gamma-irradiation-induced apoptosis by inducing bcl-2 up-regulation and inhibiting mitochondrial translocation and conformational change of bax protein. , 2003, International journal of oncology.